210 related articles for article (PubMed ID: 15751842)
1. [New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin].
Schally AV
An R Acad Nac Med (Madr); 2004; 121(3):493-500. PubMed ID: 15751842
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy targeted to cancers through tumoral hormone receptors.
Schally AV; Nagy A
Trends Endocrinol Metab; 2004 Sep; 15(7):300-10. PubMed ID: 15350601
[TBL] [Abstract][Full Text] [Related]
3. New approaches to treatment of various cancers based on cytotoxic analogs of LHRH, somatostatin and bombesin.
Schally AV; Nagy A
Life Sci; 2003 Apr; 72(21):2305-20. PubMed ID: 12639697
[TBL] [Abstract][Full Text] [Related]
4. Hypothalamic hormones and cancer.
Schally AV; Comaru-Schally AM; Nagy A; Kovacs M; Szepeshazi K; Plonowski A; Varga JL; Halmos G
Front Neuroendocrinol; 2001 Oct; 22(4):248-91. PubMed ID: 11587553
[TBL] [Abstract][Full Text] [Related]
5. Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers.
Nagy A; Schally AV
Biol Reprod; 2005 Nov; 73(5):851-9. PubMed ID: 16033997
[TBL] [Abstract][Full Text] [Related]
6. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors.
Schally AV; Nagy A
Eur J Endocrinol; 1999 Jul; 141(1):1-14. PubMed ID: 10407215
[TBL] [Abstract][Full Text] [Related]
7. Therapy of experimental hepatic cancers with cytotoxic peptide analogs targeted to receptors for luteinizing hormone-releasing hormone, somatostatin or bombesin.
Szepeshazi K; Schally AV; Treszl A; Seitz S; Halmos G
Anticancer Drugs; 2008 Apr; 19(4):349-58. PubMed ID: 18454045
[TBL] [Abstract][Full Text] [Related]
8. New treatment approaches for prostate cancer based on peptide analogues.
Stangelberger A; Schally AV; Djavan B
Eur Urol; 2008 May; 53(5):890-900. PubMed ID: 18201818
[TBL] [Abstract][Full Text] [Related]
9. New approaches to the therapy of various tumors based on peptide analogues.
Schally AV
Horm Metab Res; 2008 May; 40(5):315-22. PubMed ID: 18491250
[TBL] [Abstract][Full Text] [Related]
10. Use of analogs of peptide hormones conjugated to cytotoxic radicals for chemotherapy targeted to receptors on tumors.
Schally AV; Engel JB; Emons G; Block NL; Pinski J
Curr Drug Deliv; 2011 Jan; 8(1):11-25. PubMed ID: 21034424
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207.
Stangelberger A; Schally AV; Nagy A; Szepeshazi K; Kanashiro CA; Halmos G
Prostate; 2006 Feb; 66(2):200-10. PubMed ID: 16173040
[TBL] [Abstract][Full Text] [Related]
12. LH-RH receptors in human colorectal cancers: unexpected molecular targets for experimental therapy.
Szepeshazi K; Schally AV; Halmos G
Int J Oncol; 2007 Jun; 30(6):1485-92. PubMed ID: 17487370
[TBL] [Abstract][Full Text] [Related]
13. Potential use of analogs of luteinizing hormone-releasing hormones in the treatment of hormone-sensitive neoplasms.
Schally AV; Redding TW; Comaru-Schally AM
Cancer Treat Rep; 1984 Jan; 68(1):281-9. PubMed ID: 6362868
[TBL] [Abstract][Full Text] [Related]
14. Preclinical evaluation of therapeutic effects of targeted cytotoxic analogs of somatostatin and bombesin on human gastric carcinomas.
Szepeshazi K; Schally AV; Nagy A; Wagner BW; Bajo AM; Halmos G
Cancer; 2003 Oct; 98(7):1401-10. PubMed ID: 14508826
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the study of small peptides in targeted drug delivery system].
Sun Y; Wang C
Yao Xue Xue Bao; 2008 Oct; 43(10):992-6. PubMed ID: 19127861
[TBL] [Abstract][Full Text] [Related]
16. Targeting cytotoxic conjugates of somatostatin, luteinizing hormone-releasing hormone and bombesin to cancers expressing their receptors: a "smarter" chemotherapy.
Nagy A; Schally AV
Curr Pharm Des; 2005; 11(9):1167-80. PubMed ID: 15853664
[TBL] [Abstract][Full Text] [Related]
17. AEZS-108 : a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors.
Engel J; Emons G; Pinski J; Schally AV
Expert Opin Investig Drugs; 2012 Jun; 21(6):891-9. PubMed ID: 22577891
[TBL] [Abstract][Full Text] [Related]
18. [History of clinical studies on hypothalamic hormone analogs in Mexico].
Schally AV; González Bárcena D
Gac Med Mex; 2006; 142(4):315-25. PubMed ID: 17022307
[TBL] [Abstract][Full Text] [Related]
19. Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207.
Kahán Z; Nagy A; Schally AV; Halmos G; Arencibia JM; Groot K
Cancer; 1999 Jun; 85(12):2608-15. PubMed ID: 10375109
[TBL] [Abstract][Full Text] [Related]
20. Use of analogs of LH-RH and somatostatin for the treatment of hormone dependent cancers.
Redding TW; Schally AV
Prog Clin Biol Res; 1988; 262():217-40. PubMed ID: 2897695
[No Abstract] [Full Text] [Related]
[Next] [New Search]
